ACAT and Mouse—Inhibiting Former Prevents AD-like Pathology in Latter
Inhibiting ACAT, a cholesterol-modifying enzyme, may prove a viable therapy for preventing or slowing the progression of Alzheimer disease...
6397 RESULTS
Sort By:
Inhibiting ACAT, a cholesterol-modifying enzyme, may prove a viable therapy for preventing or slowing the progression of Alzheimer disease...
Microtubule affinity regulating kinases (MARKs) regulate transport along axonal microtubules by pulling microtubule-associated proteins, including tau, off the tracks...
Since Alois Alzheimer’s first descriptions of senile plaques, we have known that they are associated with dementia. But are they detrimental?...
Inclusion bodies: Grim reapers or guardian angels? A robotic microscope, which can monitor the health of hundreds of neurons infected with mutant huntingtin, has the answer...
New evidence suggests that DJ-1, which is mutated in some cases of early-onset Parkinson disease, acts as a chaperone that prevents aggregation of...
End of the Road for GDNF Parkinson Therapy—or Just a Detour? American Neurological Association: 2004 Annual Meeting
Infusing GDNF directly into the striatum of Parkinson disease patients fails to prevent functional decline...
A special section in the September 30 Neuron reviews some of the advances made in understanding the processes involved in learning, storing, and recollecting information...
Recent reports suggest that human umbilical cord blood cells can rescue brain neurons damaged by stroke. But curiously, the blood cells don’t have to enter the brain to be effective...
Pharmaceutical giant Merck announced today that it was withdrawing rofecoxib, a pain and antiinflammatory drug, from worldwide markets...
PPARγ has received a lot of attention from neuroscientists lately. Now, ablation of one of its partners, PGC-1α, has been found to cause...
Some NSAIDs have been shown to shift Aβ production to the shorter Aβ1-38. Now, results suggest that they do this by eliciting a conformational change in presenilin...
Researchers demonstrate the power of combining cDNA and yeast two-hybrid (Y2H) screens in pursuit of protein accomplices of disease-suspect molecules, in this case...
Paul Coleman, as editor-in-chief of Neurobiology of Aging, has initiated a policy of accepting negative results for publication...
How are protofibrils toxic? An accelerated publication suggests that they permeabilize and increase the flux of ions across lipid bilayers...
No filters selected